171 related articles for article (PubMed ID: 11480556)
1. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis.
Raspadori D; Damiani D; Lenoci M; Rondelli D; Testoni N; Nardi G; Sestigiani C; Mariotti C; Birtolo S; Tozzi M; Lauria F
Leukemia; 2001 Aug; 15(8):1161-4. PubMed ID: 11480556
[TBL] [Abstract][Full Text] [Related]
2. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
Baer MR; Stewart CC; Lawrence D; Arthur DC; Byrd JC; Davey FR; Schiffer CA; Bloomfield CD
Blood; 1997 Aug; 90(4):1643-8. PubMed ID: 9269784
[TBL] [Abstract][Full Text] [Related]
3. CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
Raspadori D; Damiani D; Michieli M; Stocchi R; Gentili S; Gozzetti A; Masolini P; Michelutti A; Geromin A; Fanin R; Lauria F
Haematologica; 2002 Nov; 87(11):1135-40. PubMed ID: 12414342
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.
Suzuki R; Murata M; Kami M; Ohtake S; Asou N; Kodera Y; Tomonaga M; Masaki Y; Kusumoto S; Takeuchi J; Matsuda S; Hirai H; Yorimitsu mS; Hamajima N; Seto M; Shimoyama M; Ohno R; Morishima Y; Nakamura S
Int J Hematol; 2003 Jun; 77(5):482-9. PubMed ID: 12841387
[TBL] [Abstract][Full Text] [Related]
5. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome.
Chang H; Brandwein J; Yi QL; Chun K; Patterson B; Brien B
Leuk Res; 2004 Oct; 28(10):1007-11. PubMed ID: 15289011
[TBL] [Abstract][Full Text] [Related]
6. Clonal selection of CD56+ t(8;21) AML blasts: further suggestion of the adverse clinical significance of this biological marker?
Daniels JT; Davis BJ; Houde-McGrail L; Byrd JC
Br J Haematol; 1999 Nov; 107(2):381-3. PubMed ID: 10583228
[TBL] [Abstract][Full Text] [Related]
7. CD56 antigen expression and hemophagocytosis of leukemic cells in acute myeloid leukemia with t(16;21)(p11;q22).
Jekarl DW; Kim M; Lim J; Kim Y; Han K; Lee AW; Kim HJ; Min WS
Int J Hematol; 2010 Sep; 92(2):306-13. PubMed ID: 20694842
[TBL] [Abstract][Full Text] [Related]
8. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21).
Iriyama N; Hatta Y; Takeuchi J; Ogawa Y; Ohtake S; Sakura T; Mitani K; Ishida F; Takahashi M; Maeda T; Izumi T; Sakamaki H; Miyawaki S; Honda S; Miyazaki Y; Taki T; Taniwaki M; Naoe T
Leuk Res; 2013 Sep; 37(9):1021-6. PubMed ID: 23810283
[TBL] [Abstract][Full Text] [Related]
9. High incidence of CD56 expression and relapse rate in acute myeloid leukemia patients with t(8;21) in Taiwan.
Hsiao CH; Tang JL; Yao M; Tsay W; Wang CH; Chen YC; Shen MC; Tien HF
J Formos Med Assoc; 2002 Jun; 101(6):393-8. PubMed ID: 12189644
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
[TBL] [Abstract][Full Text] [Related]
11. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
Yang DH; Lee JJ; Mun YC; Shin HJ; Kim YK; Cho SH; Chung IJ; Seong CM; Kim HJ
Am J Hematol; 2007 Jan; 82(1):1-5. PubMed ID: 16986129
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of CD200 and CD56 Expression in Patients with Acute Myeloid Leukemia.
Aref S; Abousamra N; El-Helaly E; Mabed M
Asian Pac J Cancer Prev; 2020 Mar; 21(3):743-748. PubMed ID: 32212802
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of CD56 antigen expression in acute myeloid leukemia.
Di Bona E; Sartori R; Zambello R; Guercini N; Madeo D; Rodeghiero F
Haematologica; 2002 Mar; 87(3):250-6. PubMed ID: 11869936
[TBL] [Abstract][Full Text] [Related]
14. FLT3-internal tandem duplication in a pediatric patient with t(8;21) acute myeloid leukemia.
Kawamura M; Kaku H; Ito T; Funata N; Taki T; Shimada A; Hayashi Y
Cancer Genet Cytogenet; 2010 Dec; 203(2):292-6. PubMed ID: 21156247
[TBL] [Abstract][Full Text] [Related]
15. A sensitive model for prediction of relapse in adult acute myeloid leukaemia with t(8;21) using white blood cell count, CD56 and MDR1 gene expression at diagnosis.
Schaich M; Koch R; Soucek S; Repp R; Ehninger G; Illmer T
Br J Haematol; 2004 May; 125(4):477-9. PubMed ID: 15142118
[TBL] [Abstract][Full Text] [Related]
16. Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome.
Thomas X; Vila L; Campos L; Sabido O; Archimbaud E
Leuk Lymphoma; 1995 Oct; 19(3-4):295-300. PubMed ID: 8535222
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia.
Djunic I; Virijevic M; Djurasinovic V; Novkovic A; Colovic N; Kraguljac-Kurtovic N; Vidovic A; Suvajdzic-Vukovic N; Tomin D
Med Oncol; 2012 Sep; 29(3):2077-82. PubMed ID: 22081445
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
19. Aberrant co-expression of CD19 and CD56 as surrogate markers of acute myeloid leukemias with t(8;21) in Taiwan.
Chen SW; Li CF; Chuang SS; Tzeng CC; Hsieh YC; Lee PS; Chen CH; Huang WT; Hwang WS; Tsao CJ
Int J Lab Hematol; 2008 Apr; 30(2):133-8. PubMed ID: 18333845
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic analysis enables the correct prediction of t(8;21) in acute myeloid leukaemia.
Ferrara F; Di Noto R; Annunziata M; Copia C; Lo Pardo C; Boccuni P; Sebastio L; Del Vecchio L
Br J Haematol; 1998 Jul; 102(2):444-8. PubMed ID: 9695958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
